Treace Medical Concepts (TMCI) Income from Continuing Operations (2020 - 2026)

Treace Medical Concepts (TMCI) has reported Income from Continuing Operations for 7 consecutive years, with -$16.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Income from Continuing Operations rose 8.25% year-over-year to -$16.1 million; the trailing twelve-month figure through Jun 2026 stood at -$57.4 million (down 15.87% YoY), and the FY2025 full-year result was -$56.7 million, down 1.12% from the prior year.
• Income from Continuing Operations rose to -$16.1 million in Q2 2026 per TMCI's latest filing, from -$18.2 million in the prior quarter.
• Across five years, Income from Continuing Operations topped out at -$619000.0 in Q4 2024 and bottomed at -$21.3 million in Q2 2024.
• Historically, Income from Continuing Operations has averaged -$13.0 million across 5 years, with a median of -$14.5 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations surged 90.29% in 2024, then sank 989.66% in 2025.
• Over 5 years, Income from Continuing Operations stood at -$4.1 million in 2022, then plunged by 57.26% to -$6.4 million in 2023, then soared by 90.29% to -$619000.0 in 2024, then tumbled by 989.66% to -$6.7 million in 2025, then sank by 138.32% to -$16.1 million in 2026.
• According to Business Quant data, Income from Continuing Operations over the past three periods registered -$16.1 million, -$18.2 million, and -$6.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.